Nuveen Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $481M | Buy |
|
|||||
|
2024
Q3 | $376M | Sell |
|
|||||
|
2024
Q2 | $342M | Sell |
|
|||||
|
2024
Q1 | $628M | Sell |
|
|||||
|
2023
Q4 | $934M | Buy |
|
|||||
|
2023
Q3 | $855M | Buy |
|
|||||
|
2023
Q2 | $755M | Buy |
|
|||||
|
2023
Q1 | $769M | Buy |
|
|||||
|
2022
Q4 | $743M | Buy |
|
|||||
|
2022
Q3 | $493M | Buy |
|
|||||
|
2022
Q2 | $425M | Sell |
|
|||||
|
2022
Q1 | $455M | Sell |
|
|||||
|
2021
Q4 | $653M | Sell |
|
|||||
|
2021
Q3 | $648M | Buy |
|
|||||
|
2021
Q2 | $611M | Buy |
|
|||||
|
2021
Q1 | $564M | Buy |
|
|||||
|
2020
Q4 | $280M | Buy |
|
|||||
|
2020
Q3 | $300M | Sell |
|
|||||
|
2020
Q2 | $490M | Sell |
|
|||||
|
2020
Q1 | $930M | Buy |
|
|||||
|
2019
Q4 | $540M | Sell |
|
|||||
|
2019
Q3 | $622M | Sell |
|
|||||
|
2019
Q2 | $665M | Buy |
|
|||||
|
2019
Q1 | $48.9M | Buy |
|
|||||
|
2018
Q4 | $35.3M | Sell |
|
|||||
|
2018
Q3 | $48.6M | Buy |
|
|||||
|
2018
Q2 | $44.3M | Sell |
|
|||||
|
2018
Q1 | $51.7M | Sell |
|
|||||
|
2017
Q4 | $70M | Buy |
|
|||||
|
2017
Q3 | $69.7M | Buy |
|
|||||
|
2017
Q2 | $50.1M | Buy |
|
|||||
|
2017
Q1 | $47.4M | Sell |
|
|||||
|
2016
Q4 | $56.9M | Buy |
|
|||||
|
2016
Q3 | $52.3M | Sell |
|
|||||
|
2016
Q2 | $58.3M | Sell |
|
|||||
|
2016
Q1 | $69.5K | Buy |
|
|||||
|
2015
Q4 | $73.2K | Sell |
|
|||||
|
2015
Q3 | $71.1K | Sell |
|
|||||
|
2015
Q2 | $86.8K | Sell |
|
|||||
|
2015
Q1 | $73.2M | Sell |
|
|||||
|
2014
Q4 | $72.7M | Buy |
|
|||||
|
2014
Q3 | $70.6M | Sell |
|
|||||
|
2014
Q2 | $57.5M | Sell |
|
|||||
|
2014
Q1 | $59.6M | Buy |
|
|||||
|
2013
Q4 | $62M | Sell |
|
|||||
|
2013
Q3 | $60.9M | Sell |
|
|||||
|
2013
Q2 | $54.2M | Buy |
|